INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | - | ₹0.70 Cr | ₹10 Cr | ₹0.50 Cr | ₹0.50 Cr |
What is the latest Contingent Liabilities ratio of INDEGENE ?
Year | Contingent Liabilities |
---|---|
Mar2025 | - |
Mar2024 | ₹0.70 Cr |
Mar2023 | ₹10 Cr |
Mar2022 | ₹0.50 Cr |
Mar2021 | ₹0.50 Cr |
How is Contingent Liabilities of INDEGENE Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | - | -100.00 | |
Mar2024 | ₹0.70 Cr | -93.07 | |
Mar2023 | ₹10 Cr | 1,924.05 | |
Mar2022 | ₹0.50 Cr | 0.00 | |
Mar2021 | ₹0.50 Cr | - |
Compare Contingent Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,652.1 Cr | 1.2% | -0.6% | -16.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,167.0 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 1.2% |
-0.6% |
-16.4% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses